NASDAQ:ALBO
Albireo Pharma, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.albireopharma.comipo date
May 11, 2007
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus